International Journal of Cardiology
Volume 139, Issue 1 , Pages 68-74 , 18 February 2010

Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions

Received 28 May 2008 ,Accepted 1 October 2008.

References 

  1. Di Mario C, Werner GS, Sianos G, et al. for the EuroCTO club. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroInterv. 2007;3:30–43
  2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936
  3. Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, et al. Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis. Rev Esp Cardiol. 2007;60:1010–1014
  4. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–1785
  5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–375
  6. Gruber L. Clinical features and prognostic implications of contrast-induced nephropathy. In:  Bartorelli AL,  Marenzi G editor. Contrast-induced nephropathy. London: Taylor & Francis; 2006;p. 35–45
  7. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–1519
  8. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005;64:442–448
  9. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264
  10. Tepel M, van der GM, Schwarzfeld C, Laufer U, Liermann D. SIDEC W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180–184
  11. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542–1548
  12. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology—National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol. 2001;37:2240–2245
  13. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol. 2008;101:812–819
  14. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399
  15. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13–19
  16. Barlis P, Kaplan S, Dimopoulos K, Tanigawa J, Schultz C, Di Mario C. An indeterminate occlusion duration predicts procedural failure in the recanalization of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2008;71:621–628
  17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  18. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–470
  19. Brown JR, DeVries JT, Piper WD, et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J. 2008;155:260–266
  20. Nikolsky E, Mehran R, Turcot D, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol. 2004;94:300–305
  21. Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio. A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50:584–590
  22. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86:649–652
  23. Freeman RV, O'Donnell MO, Share D, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90:1068–1073
  24. Meharn R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. 2006;69:S11–S15
  25. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264
  26. Weisbord SD, Hartwig KC, Sonel AF, Fine MJ, Palevsky P, et al. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheter Cardiovasc Interv. 2008;15:
  27. Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol. 2008;21:74–85
  28. Briguori C, Airoldi F, D'Andrea D, et al. Renal insufficiency following contrast media administration trial (REMEDIAL) a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211–1217
  29. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int. 2006;69(Suppl S100):S16–S19
  30. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int. 1998;53:230–242
  31. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Eng J Med. 2006;354:2773–2782
  32. Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J. 2006;151:140–145
  33. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 1993;188:171–178
  34. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491–499
  35. Solomon RJ, Natarajan MK, Doucet S, et al. Cardiac angiography in renally impaired patients (CARE) study. A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115:3189–3196
  36. From AM, Bartholmai BJ, Williams AW, McDonald FS. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study. Acta Radiol. 2008;49:409–414
  37. Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc—preliminary results. Nephrol Dial Transplant. 2008;23:1241–1245
  38. Albert SG, Shapiro MJ, Brown WW, et al. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol. 1994;29:618–623
  39. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol. 2002;89:356–358
  40. Kahn JK, Rutherford BD, McConahay DR, et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J. 1990;120:533–536
  41. Rosovsky MA, Rusinek H, Berenstein A, et al. High-dose administration of nonionic contrast media: a retrospective review. Radiology. 1996;200:119–122
  42. Di Mario C, Barlis P, Tanigawa J, et al. Retrograde approach to coronary chronic total occlusions: preliminary single European centre experience. EuroInterv. 2007;3:181–187
  43. Sianos G, Barlis P, Di Mario C, et al. European experiences with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the EuroCTO club. EuroInterv. 2008;4:84–92
  44. Stevens MA, McCullough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study: prevention of radiocontrast induced nephropathy clinical evaluation. J Am Coll Cardiol. 1999;33:403–411
  45. Guitterez NV, Diaz A, Timmis GC, et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol. 2002;15:349–354
  46. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

☆ All the authors declare absence of any conflict of interest.

PII: S0167-5273(08)01052-8

doi: 10.1016/j.ijcard.2008.10.006

International Journal of Cardiology
Volume 139, Issue 1 , Pages 68-74 , 18 February 2010

Article Tools

* Image Usage & Resolution